1,135
Participants
Start Date
October 17, 2020
Primary Completion Date
July 25, 2021
Study Completion Date
July 25, 2021
SARS-CoV-2 Antibody Analysis
10 ml of blood will be drawn for antibody analysis. Participants who test SARCS-CoV-2 positive will be invited to participate in follow-up antibody testing at 4 weeks and at 3 months.
Weck-cel Swab Collection
A Weck-cel swab will be used to collect secretions from the mucosal epithelium
Web Based Questionnaire
A brief web enabled questionnaire will be administered to collect information related to demographics, SARS-CoV-2 exposure history, past symptoms, comorbidities associates with increased infection and disease risk, as well as immunosuppression status and use to immunosuppressive medications.
Moffitt Cancer Center, Tampa
Merck Sharp & Dohme LLC
INDUSTRY
H. Lee Moffitt Cancer Center and Research Institute
OTHER